Physician profile
Michael Garrett
NPI 1487672770
$2,593.80
in general payments reported to CMS, 2019-2025
38 companies · $980 in 2025
The $980 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $609 · 2023: $262 · 2024: $443 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $261.95 | 2021-2024 | Axonics |
| Sumitomo Pharma America, INC. | $213.89 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $213.27 | 2021-2025 | |
| Astellas Pharma US INC | $206.81 | 2021-2025 | Xtandi, Izervay |
| Teleflex LLC | $180.57 | 2022-2025 | Urolift |
| Boston Scientific Corporation | $149.57 | 2025 | Axonics |
| Endo Pharmaceuticals INC. | $128.83 | 2021-2023 | Aveed, Xiaflex, Edex |
| Valencia Technologies Corporation | $125.00 | 2025 | Ecoin Device Kit |
| Janssen Biotech, INC. | $93.84 | 2021-2024 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $79.29 | 2024-2025 | Provenge |
| Antares Pharma, INC. | $71.53 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $66.53 | 2023-2025 | Jelmyto |
| Pfizer INC. | $63.45 | 2024-2025 | |
| Rxsight INC | $53.30 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Tolmar Pharmaceuticals, INC. | $52.67 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $51.86 | 2022-2023 | |
| Convatec INC. | $49.59 | 2025 | |
| Laborie Medical Technologies Corp. | $47.32 | 2024 | Endosheath Technology, Optilume Bph Drug Coated Balloon Catheter |
| Ferring Pharmaceuticals INC. | $45.15 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $41.46 | 2021-2025 | Posluma |
| Bioprotect Medical, INC. | $38.94 | 2025 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $35.44 | 2023-2025 | |
| Palette Life Sciences, INC. | $27.59 | 2022 | |
| Amgen INC. | $27.13 | 2021-2022 | |
| Urovant Sciences INC | $25.46 | 2021-2022 | |
| Photocure INC | $23.94 | 2025 | Cysview |
| Telix Pharmaceuticals | $23.03 | 2025 | Illuccix |
| Edap Technomed INC | $22.66 | 2025 | |
| Genzyme Corporation | $22.13 | 2023 | |
| Alnylam Pharmaceuticals INC. | $19.73 | 2025 | Oxlumo |
| Endo USA, INC. | $19.70 | 2025 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $19.44 | 2024 | Lynparza |
| Clarus Therapeutics INC. | $17.11 | 2021 | |
| Healthtronics Stone Solutions, LLC | $16.67 | 2022 | |
| Myriad Genetic Laboratories, INC. | $16.05 | 2024 | Prolaris |
| Novartis Pharmaceuticals Corporation | $15.55 | 2025 | |
| Dentsply Ih Ab | $14.48 | 2023 | Lofric |
| Coloplast Corp | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.